Plasma sex steroid hormones and risk of developing type 2 diabetes in women: a prospective study

[1]  JoAnn E Manson,et al.  Accuracy of Administrative Coding for Type 2 Diabetes in Children, Adolescents, and Young Adults , 2007, Diabetes Care.

[2]  D. Ludwig,et al.  Accuracy of Administrative Coding for Type 2 Diabetes in Children, Adolescents, and Young Adults , 2007, Diabetes Care.

[3]  L. de Jong-van den Berg,et al.  Selection of controls in case-control studies on maternal medication use and risk of birth defects. , 2007, Birth defects research. Part A, Clinical and molecular teratology.

[4]  J. Manson,et al.  Circulating Levels of Endothelial Adhesion Molecules and Risk of Diabetes in an Ethnically Diverse Cohort of Women , 2007, Diabetes.

[5]  M. Szklo,et al.  Endogenous sex hormones and glucose tolerance status in postmenopausal women. , 2007, The Journal of clinical endocrinology and metabolism.

[6]  C. Cobelli,et al.  Two Years of Treatment With Dehydroepiandrosterone Does Not Improve Insulin Secretion, Insulin Action, or Postprandial Glucose Turnover in Elderly Men or Women , 2007, Diabetes.

[7]  P. Taylor,et al.  Usefulness of Body Mass Index as a Sufficient Adiposity Measurement for Sex Hormone Concentration Associations in Postmenopausal Women , 2006, Cancer Epidemiology Biomarkers & Prevention.

[8]  Claudio Cobelli,et al.  DHEA in elderly women and DHEA or testosterone in elderly men. , 2006, The New England journal of medicine.

[9]  J. Manson,et al.  Vitamin E and Risk of Type 2 Diabetes in the Women’s Health Study Randomized Controlled Trial , 2006, Diabetes.

[10]  E. Ding,et al.  Endogenous Sex Hormones and Type 2 Diabetes Risk—Reply , 2006 .

[11]  J. Ruderman.  Faculty Opinions recommendation of The estrogenic effect of bisphenol A disrupts pancreatic beta-cell function in vivo and induces insulin resistance. , 2006 .

[12]  E. Ding,et al.  Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis. , 2006, JAMA.

[13]  J. Manson,et al.  Sex hormone-binding globulin and serum testosterone are inversely associated with C-reactive protein levels in postmenopausal women at high risk for cardiovascular disease. , 2006, Annals of epidemiology.

[14]  G. Heiss,et al.  The effect of conjugated equine oestrogen on diabetes incidence: the Women’s Health Initiative randomised trial , 2006, Diabetologia.

[15]  R. Little,et al.  Androgens are associated with hemostatic and inflammatory factors among women at the mid-life. , 2005, The Journal of clinical endocrinology and metabolism.

[16]  G. Ankley,et al.  Screening and Testing for Endocrine Disruption in Fish—Biomarkers As “Signposts,” Not “Traffic Lights,” in Risk Assessment , 2005, Environmental health perspectives.

[17]  Paloma Alonso-Magdalena,et al.  The Estrogenic Effect of Bisphenol A Disrupts Pancreatic β-Cell Function In Vivo and Induces Insulin Resistance , 2005, Environmental health perspectives.

[18]  C. Stehouwer,et al.  Effects of transdermal and oral postmenopausal hormone therapy on vascular function: a randomized, placebo-controlled study in healthy postmenopausal women , 2005, Menopause.

[19]  K. Nair,et al.  Effect of dehydroepiandrosterone replacement on insulin sensitivity and lipids in hypoadrenal women. , 2005, Diabetes.

[20]  J. Holloszy,et al.  Effect of DHEA on abdominal fat and insulin action in elderly women and men: a randomized controlled trial. , 2004, JAMA.

[21]  W. Roberts,et al.  Performance characteristics of eight estradiol immunoassays. , 2004, American journal of clinical pathology.

[22]  B. Howard,et al.  Effect of oestrogen plus progestin on the incidence of diabetes in postmenopausal women: results from the Women’s Health Initiative Hormone Trial , 2004, Diabetologia.

[23]  J. Manson,et al.  Hemoglobin A1c level and future cardiovascular events among women. , 2004, Archives of Internal Medicine.

[24]  T. Strandberg,et al.  Differing effects of oral and transdermal hormone replacement therapy on cardiovascular risk factors in healthy postmenopausal women. , 2003, The American journal of cardiology.

[25]  M. Tschöp,et al.  Anti-androgen treatment increases circulating ghrelin levels in obese women with polycystic ovary syndrome , 2003, Journal of endocrinological investigation.

[26]  B. Gulanski,et al.  Association of endogenous sex hormones and insulin resistance among postmenopausal women: results from the Postmenopausal Estrogen/Progestin Intervention Trial. , 2003, The Journal of clinical endocrinology and metabolism.

[27]  E. Vittinghoff,et al.  Glycemic Effects of Postmenopausal Hormone Therapy: The Heart and Estrogen/progestin Replacement Study: A Randomized, Double-Blind, Placebo-Controlled Trial , 2003, Annals of Internal Medicine.

[28]  E. Riboli,et al.  Validity of free testosterone and free estradiol determinations in serum samples from postmenopausal women by theoretical calculations. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[29]  M. Cazzaniga,et al.  Effect of Transdermal Estradiol and Oral Conjugated Estrogen on C-Reactive Protein in Retinoid-Placebo Trial in Healthy Women , 2002, Circulation.

[30]  D. Dunger,et al.  Additive effects of insulin-sensitizing and anti-androgen treatment in young, nonobese women with hyperinsulinism, hyperandrogenism, dyslipidemia, and anovulation. , 2002, The Journal of clinical endocrinology and metabolism.

[31]  M. Taskinen,et al.  Effects of Oral and Transdermal Estrogen Replacement Therapy on Markers of Coagulation, Fibrinolysis, Inflammation and Serum Lipids and Lipoproteins in Postmenopausal Women , 2001, Thrombosis and Haemostasis.

[32]  M. Taskinen,et al.  Differential Effects of Oral and Transdermal Estrogen Replacement Therapy on Endothelial Function in Postmenopausal Women , 2000, Circulation.

[33]  M. Espeland,et al.  Effect of Postmenopausal Hormone Therapy on Glucose and Insulin Concentrations , 1998, Diabetes Care.

[34]  A. O’Sullivan,et al.  The route of estrogen replacement therapy confers divergent effects on substrate oxidation and body composition in postmenopausal women. , 1998, The Journal of clinical investigation.

[35]  F. Soria,et al.  Elecsys testosterone assay evaluated. , 1998, Clinical chemistry.

[36]  J. Rood,et al.  Exogenous androgens influence body composition and regional body fat distribution in obese postmenopausal women--a clinical research center study. , 1996, The Journal of clinical endocrinology and metabolism.

[37]  P. Björntorp,et al.  Mechanisms Behind Insulin Resistance in Rat Skeletal Muscle After Oophorectomy and Additional Testosterone Treatment , 1996, Diabetes.

[38]  P. Björntorp.  The regulation of adipose tissue distribution in humans. , 1996, International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity.

[39]  J. Manson,et al.  Reproducibility of plasma hormone levels in postmenopausal women over a 2-3-year period. , 1995, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[40]  F. Berrino,et al.  Validity for epidemiological studies of long-term cryoconservation of steroid and protein hormones in serum and plasma. , 1995, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[41]  R. Heine,et al.  Induction of insulin resistance by androgens and estrogens. , 1994, The Journal of clinical endocrinology and metabolism.

[42]  R. Lobo,et al.  Insulin sensitivity is decreased in normal women by doses of ethinyl estradiol used in oral contraceptives. , 1993, American journal of obstetrics and gynecology.

[43]  R. Lobo,et al.  A possible bimodal effect of estrogen on insulin sensitivity in postmenopausal women and the attenuating effect of added progestin. , 1993, Fertility and sterility.

[44]  P. Fioretti,et al.  Effects of low doses of transdermal 17 beta-estradiol on carbohydrate metabolism in postmenopausal women. , 1992, The Journal of clinical endocrinology and metabolism.

[45]  D. Silverman,et al.  Selection of controls in case-control studies. I. Principles. , 1992, American journal of epidemiology.

[46]  J K McLaughlin,et al.  Selection of controls in case-control studies. III. Design options. , 1992, American journal of epidemiology.

[47]  P. Buytaert,et al.  Carbohydrate metabolism during hormonal substitution therapy. , 1989, Maturitas.

[48]  M. Peacock,et al.  COMPARISON OF THE EFFECTS OF ORAL AND TRANSDERMAL OESTRADIOL ADMINISTRATION ON OESTROGEN METABOLISM, PROTEIN SYNTHESIS, GONADOTROPHIN RELEASE, BONE TURNOVER AND CLIMACTERIC SYMPTOMS IN POSTMENOPAUSAL WOMEN , 1989, Clinical endocrinology.

[49]  R. Schlaghecke,et al.  [Stability of steroids in plasma over a 10-year period]. , 1985, Journal of clinical chemistry and clinical biochemistry. Zeitschrift fur klinische Chemie und klinische Biochemie.

[50]  T. Bäckström,et al.  Calculation of free and bound fractions of testosterone and estradiol-17 beta to human plasma proteins at body temperature. , 1982, Journal of steroid biochemistry.

[51]  L. Wallentin,et al.  Metabolic and hormonal effects of post-menopausal oestrogen replacement treatment. I. Glucose, insulin and human growth hormone levels during oral glucose tolerance tests. , 1977, Acta endocrinologica.

[52]  L. Wallentin,et al.  METABOLIC AND HORMONAL EFFECTS OF POST-MENOPAUSAL OESTROGEN REPLACEMENT TREATMENT , 1977 .

[53]  Kalkhoff Rk,et al.  Sex steroid influence on hepatic gluconeogenesis and glycogen formation. , 1971 .

[54]  Thomas R. Riley,et al.  A Randomized Double-blind Placebo-controlled Trial , 2004 .

[55]  F. Berrino,et al.  Free estradiol and breast cancer risk in postmenopausal women: comparison of measured and calculated values. , 2003, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[56]  E. Barrett-Connor,et al.  Endogenous sex hormones and the development of type 2 diabetes in older men and women: the Rancho Bernardo study. , 2002, Diabetes care.

[57]  Ose,et al.  Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events* , 2002 .

[58]  M. L. Matute,et al.  Sex steroid influence on hepatic gluconeogenesis and glycogen formation. , 1971, The Journal of laboratory and clinical medicine.